Primary ILM peeling prevents macula pucker development

Article

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes.

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes, claims a study in the journal Retina.

The investigation, led by Dr D. Odrobina, Klinika Okulistyczna, Poland, included of 84 patients who underwent retinectomy with silicone oil tamponade for retinal detachment caused by proliferative vitreoretinopathy.

Eyes were split into two groups with 33 eyes in group A and 51 eyes in group B. In group A the ILM was peeled and in group B the ILM was not peeled. The effect of ILM peeling for the prevention of macula pucker was determined by slit-lamp examination.

The first month after retinectomy revealed cases of extramacular epiretinal cellular proliferation in 3 eyes in group A and 3 eyes in group B. In the final follow-up there were no macular pucker cases in group A and 9 cases of macula pucker in group B.

Eyes with retinal detachment caused by proliferative vitreoretinopathy were successfully treated by retinectomy and silicone oil tamponade. Primary peeling of the ILM is a successful method of preventing the development of macula pucker.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.